658 related articles for article (PubMed ID: 31755111)
1. The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
Schwedt TJ; Digre K; Tepper SJ; Spare NM; Ailani J; Birlea M; Burish M; Mechtler L; Gottschalk C; Quinn AM; McGillicuddy L; Bance L; Dumkrieger G; Chong CD; Dodick DW
Headache; 2020 Feb; 60(2):337-347. PubMed ID: 31755111
[TBL] [Abstract][Full Text] [Related]
2. Sensory Hypersensitivity Symptoms in Migraine With vs Without Aura: Results From the American Registry for Migraine Research.
Pearl TA; Dumkrieger G; Chong CD; Dodick DW; Schwedt TJ
Headache; 2020 Mar; 60(3):506-514. PubMed ID: 31965576
[TBL] [Abstract][Full Text] [Related]
3. Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
Pearl TA; Dumkrieger G; Chong CD; Dodick DW; Schwedt TJ
Headache; 2020 Oct; 60(9):1910-1919. PubMed ID: 32749685
[TBL] [Abstract][Full Text] [Related]
4. Photophobia Contributes to Migraine-Associated Disability and Reduced Work Productivity: Results From the American Registry for Migraine Research (ARMR).
Leibovit-Reiben Z; Dumkrieger G; Dodick DW; Digre K; Chong CD; Trivedi M; Schwedt TJ
J Neuroophthalmol; 2024 Jun; 44(2):259-266. PubMed ID: 37581595
[TBL] [Abstract][Full Text] [Related]
5. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB
Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007
[TBL] [Abstract][Full Text] [Related]
6. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
Tepper SJ; Fang J; Zhou L; Shen Y; Vo P; Abdrabboh A; Glassberg MB; Ferraris M
J Manag Care Spec Pharm; 2021 Sep; 27(9):1157-1170. PubMed ID: 33998825
[No Abstract] [Full Text] [Related]
8. The impact of pre-morbid headaches on headache features and long-term health outcomes following traumatic brain injury: Insights from the American Registry for Migraine Research.
Leibovit-Reiben Z; Ishii R; Dodick DW; Dumkrieger G; Cortez MM; Brennan KC; Digre K; Schwedt TJ
Headache; 2022 May; 62(5):566-576. PubMed ID: 35593782
[TBL] [Abstract][Full Text] [Related]
9. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
Schwedt TJ; Hentz JG; Sahai-Srivastava S; Spare NM; Martin VT; Treppendahl C; Digre K; Bennett NL; Birlea M; Watson D; Murinova N; Robert T; Dodick DW;
Headache; 2021 Feb; 61(2):351-362. PubMed ID: 33432635
[TBL] [Abstract][Full Text] [Related]
10. Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
Kawata AK; Shah N; Poon JL; Shaffer S; Sapra S; Wilcox TK; Shah S; Tepper SJ; Dodick DW; Lipton RB
Headache; 2021 Mar; 61(3):438-454. PubMed ID: 33594686
[TBL] [Abstract][Full Text] [Related]
11. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
12. Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine.
Robblee J; Devick KL; Mendez N; Potter J; Slonaker J; Starling AJ
Headache; 2020 Oct; 60(9):2014-2025. PubMed ID: 32920850
[TBL] [Abstract][Full Text] [Related]
13. Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort : Results from 'Migraine in Poland'-a nationwide cross-sectional survey.
Waliszewska-Prosół M; Straburzyński M; Czapińska-Ciepiela EK; Nowaczewska M; Gryglas-Dworak A; Budrewicz S
J Headache Pain; 2023 Apr; 24(1):40. PubMed ID: 37041492
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
15. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
[TBL] [Abstract][Full Text] [Related]
16. Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trial.
Shao SC; Hentz J; Shank P; Leonard M; Dodick DW; Schwedt TJ
Headache; 2024 Jun; 64(6):632-642. PubMed ID: 38780360
[TBL] [Abstract][Full Text] [Related]
17. Headache Education Active-Waiting Directive: A Program to Enhance Well-Being During Long Referral Wait Times.
Lagman-Bartolome AM; Lawler V; Lay C
Headache; 2018 Jan; 58(1):109-117. PubMed ID: 29131328
[TBL] [Abstract][Full Text] [Related]
18. The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics.
Karlsson WK; Ashina H; Cullum CK; Christensen RH; Al-Khazali HM; Amin FM; Ashina M;
J Headache Pain; 2023 Jun; 24(1):70. PubMed ID: 37303034
[TBL] [Abstract][Full Text] [Related]
19. Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine.
Hagan KK; Li W; Mostofsky E; Bertisch SM; Vgontzas A; Buettner C; Mittleman MA
Headache; 2021 Mar; 61(3):493-499. PubMed ID: 33349935
[TBL] [Abstract][Full Text] [Related]
20. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.
Evers S; Dell'Agnello G; Novick D; Gonderten HS; Panni T; Pascual J
Pain Ther; 2024 Jun; 13(3):589-607. PubMed ID: 38625512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
